Clinical Trials
2 trialsNCT03402880 2026-05-29
ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer
City of Hope Medical Center
Phase 2 Withdrawn
NCT02359019 2022-10-14
MK-3475 as Maintenance Therapy in Extensive Stage SCLC
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed